6277-45-8

Usage

Uses

Used in Organic Synthesis:
1-[2-(4-methylphenyl)-2-oxoethyl]pyridinium is used as a key intermediate in the synthesis of various organic compounds, contributing to the development of new chemical entities with diverse applications.
Used in Pharmaceutical Research:
In pharmaceutical research, 1-[2-(4-methylphenyl)-2-oxoethyl]pyridinium is utilized as a crucial component in the preparation of pharmaceuticals, potentially leading to the discovery of novel drugs with improved therapeutic effects.
Used as a Corrosion Inhibitor:
1-[2-(4-methylphenyl)-2-oxoethyl]pyridinium is employed as a corrosion inhibitor, helping to protect materials from degradation and extending their service life in various industrial applications.
Used for Antimicrobial and Anti-Fungal Applications:
1-[2-(4-methylphenyl)-2-oxoethyl]pyridinium is used for its antimicrobial and antifungal properties, making it a potential candidate for use in sanitizing products and treatments to combat microbial infections.
Used in Disease Treatment Research:
In the field of disease treatment research, 1-[2-(4-methylphenyl)-2-oxoethyl]pyridinium is studied for its potential use in treating various diseases, such as cancer and Alzheimer's, due to its ability to modulate certain biological pathways. Further research is required to explore its full therapeutic potential.

Upstream product

• 110-86-1 pyridine 
• 122-00-9 para-methylacetophenone 

Downstream Products

• 1204579-10-1 2-(5-chlorothiophen-2-yl)-4-(furan-3-yl)-6-p-tolyl-pyridine 
• 1204579-21-4 4-(5-chlorofuran-2-yl)-2-(5-chlorothiophen-2-yl)-6-p-tolyl-pyridine 
• 1384987-37-4 diethyl 2-p-tolyl-5H-chromeno[4,3-b]pyridin-4-ylphosphonate 
• 1258498-70-2 benzo[d]oxazol-2-yl(p-tolyl)methanone 
• 1514926-49-8 C₂₂H₂₁NO₅ 
• 1569317-61-8 12-(4-methylbenzoyl)-5H-cyclohepta[1,2-b:3,4-b':5,6-b'']trinaphthalene-5,6,11,13,18,19(12H)-hexaone 
• 1225015-16-6 4-(5-chlorofuran-2-yl)-2-(thiophen-2-yl)-6-p-tolylpyridine 
• 105688-38-8 1-[(Z)-2-(4-Dimethylamino-phenyl)-1-(4-methyl-benzoyl)-vinyl]-pyridinium; iodide 

Relevant academic research and scientific papers

Cyclization of Active Methylene Isocyanides with α-Oxodithioesters Induced by Base: An Expedient Synthesis of 4-Methylthio/Ethoxycarbonyl-5-acylthiazoles

Cyclization of tosylmethyl isocyanide with α-oxodithioesters in the presence of KOH is reported for the synthesis of 4-methylthio-5-acylthiazoles. Similarly, ethyl isocyanoacetate underwent cyclization with α-oxodithioesters to form 4-ethoxycarbonyl-5-acy

NANOSCALE METAL-ORGANIC LAYERS AND METAL-ORGANIC NANOPLATES FOR X-RAY INDUCED PHOTODYNAMIC THERAPY, RADIOTHERAPY, RODIODYNAMIC THERAPY, CHEMOTHERAPY, IMMUNOTHERAPY, AND ANY COMBINATION THEREOF

Metal-organic layers (MOLs) and metal-organic nanoplates (MOPs) comprising photosensitizers are described. The MOLs and MOPs can also include moieties capable of absorbing X-rays or other ionizing irradiation energy and/or scintillation. Optionally, the p

Acid-Catalyzed Condensation of o-Phenylenediammines and o-Aminophenols with α-Oxodithioesters: A Divergent and Regio? selective Synthesis of 2-Methylthio-3-Aryl/Heteroarylquinoxalines and 2-Acylbenzoxazoles

o-Phenylenediammines and o-Aminophenols were reacted with α-oxodithioesters in a highly regioselective fashion to give 2-methylthio-3-Aryl/heteroarylquinoxalines and 2-Acylbenzoxazoles in 55-94percent and 45-86percent, respectively, in the presence of p-T

Nanoscale Metal–Organic Layers for Deeply Penetrating X-ray-Induced Photodynamic Therapy

We report the rational design of metal–organic layers (MOLs) that are built from [Hf6O4(OH)4(HCO2)6] secondary building units (SBUs) and Ir[bpy(ppy)2]+- or [Ru(bpy)3]

Coupling of azomethine ylides with nitrilium derivatives of closo-decaborate clusters: A synthetic and theoretical study

The azomethine ylides p-R3C5H4N+CHCOC 6H4R2-p (3a: R3=H, R2=H, X=Br; 3b: R3=H, R2=Me, X=I; 3c: R3=H, R2=OMe, X=I; 3d: R3=H, R2=F, X=I; 3e: R3=Me, R2=Me, X=Br) react with the nitrile functio

2-Thienyl-4-furyl-6-aryl pyridine derivatives: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study

Designed and synthesized 60 2-thienyl-4-furyl-6-aryl pyridine derivatives were evaluated for their topoisomerase I and II inhibitory activities at 20 μM and 100 μM and cytotoxicity against several human cancer cell lines. Compounds 8, 9, 11-29 showed sign

Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship

A series of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives were designed, synthesized, and evaluated for their topoisomerase I and II inhibition and cytotoxic activity against several human cancer cell lines. Compounds 10-19 showed moderate

SYNTHESIS AND STRUCTURAL STUDY ON Α-SUBSTITUED-1-STYRYLPYRIDINIUM SALTS. REINVESTIGATION OF KROHNKE CONDENSATION

Kroehnke condensation of several cycloimmonium salts with p-dimethylaminobenzaldehyde has been studied.X-Ray diffraction, IR and Raman spectra, 1H- and 13C-NMR and UV spectra of the products are discussed, being compared, when necessary, with the starting pyridinium salts.All compounds showed the Z configuration, corresponding to the more stable structure, except one, in which steric factors were predominant.